Advertisement
Research ArticleArticle

S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol

Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol

Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
Journal of Pharmacology and Experimental Therapeutics September 1, 1998, 286 (3) 1356-1373;
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement